Presentation TCT 2012

Atorvastatin, Administered at the Onset of Reperfusion, Protects Human Myocardium Against Lethal Reperfusion Injury by Activation of the RISK pathway

Presenter: Paul S. Rees, Derek J. Hausenloy, Derek M. Yellon

January 03, 2012

REGISTER for free or LOG IN to view this content

Atorvastatin, Administered at the Onset of Reperfusion, Protects Human Myocardium Against Lethal Reperfusion Injury by Activation of the RISK pathway

CAD Pharma

Lipids

Presentation

TCT 2012

Up Next

Presentation TCT 2012

Evaluation of Drug Tissue Concentration Following Stenting in a Healthy Rabbit Iliac Model

Presenter: Alexander Sheehy

January 03, 2012

More slides +

Presentation TCT 2012

High Concentration Sodium Bicarbonate for the Prevention Of Contrast-induced Nephropathy.

Presenter: Nozomu Tamai

January 03, 2012

Presentation TCT 2012

Radial Versus Femoral Approach for Primary Percutaneous Coronary Intervention In Patients with Acute Myocardial Infarction: an Update Meta-analysis.

Presenter: Jae-Sik Jang

January 03, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.